Skip to main content
NVCT
NASDAQ Life Sciences

Cash Swells to $140.7M With Runway to 2H 2029 as Dual INDs Target Year-End

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$19.34
Mkt Cap
$631.336M
52W Low
$5.55
52W High
$29.275
52W Position info
248% above low
Off High info
34% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

NVCT has more than doubled off its 52-week low of $5.55.

Summary

Nuvectis ended Q3 with $140.7 million in cash, up from $31.6 million at year-end 2025, after a $115 million July follow-on and $39.5 million raised through the ATM. Management says that funds operations into the second half of 2029, well past the near-term regulatory milestones. The $30.1 million quarterly net loss is mostly accounting optics: it includes the $20.0 million Haisco license upfront and $1.8 million of NXP900 milestones, leaving roughly $5.8 million of underlying burn, and the quarter's EPS came in at USD -1.02. The real news is timing — FDA discussions on a US PNH path for ciprocopan (NXP100) are underway with an update promised before year-end, and US IND submissions for both NXP100 and NXP200 are expected by year-end. NXP200's ESMO data showed a 40.0% ORR in high-grade glioma and 42.9% in low-grade glioma, with deep responses in most responders. Watch the year-end FDA update and the two IND filings as the next hard checkpoints.

At the time of this announcement, NVCT was trading at $19.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $631.3M. The 52-week trading range was $5.55 to $29.28. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NVCT - Latest Insights

NVCT
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $19.42
Real-time Price: $19.12 info
Change: -$0.300 (-2%) info
Market Cap: $658.052M info
NVCT
Nov 04, 2026, 8:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.34
Real-time Price: $19.12 info
Change: -$0.220 (-1%) info
Market Cap: $658.052M info
NVCT
Oct 26, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $20.05
Real-time Price: $19.12 info
Change: -$0.930 (-5%) info
Market Cap: $658.052M info
NVCT
Sep 24, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.70
Real-time Price: $19.12 info
Change: -$2.58 (-12%) info
Market Cap: $658.052M info
NVCT
Aug 21, 2026, 4:37 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $23.56
Real-time Price: $19.12 info
Change: -$4.44 (-19%) info
Market Cap: $658.052M info